2+ week, 5+ day ago   (274+ words) Mission Prep now offers a Joint Commission accredited-residential treatment program in Bonsall, San Diego County - offering professional support for teenage boys struggling with depression and anxiety. The news comes as Mission Prep warns that untreated, depression can quickly escalate to…...

1+ mon, 2+ week ago   (416+ words) markets.businessinsider.com TRT Australia Releases Guide On Low T Symptoms & Long-Term Health Impacts In Men TRT Australia has published a guide on low testosterone and how it may impact men. The guide covers common symptoms, potential health implications, treatments,…...

2+ mon, 3+ day ago   (239+ words) Addressing rapidly evolving demand and growing rifts in treatment access, TRT Australia has expanded their telehealth testosterone treatment services to the greater Perth area. Hurstville, Australia, July 9, 2026 -- TRT Australia has expanded access to its telehealth-supported testosterone treatment pathway for eligible…...

2+ mon, 1+ week ago   (184+ words) FDA’s rolling review process is intended to facilitate expedited review, enabling FDA to begin evaluating completed modules of the NDA before the full application is submitted FDA previously granted Breakthrough Therapy and Fast Track designations for QTORIN™ rapamycin, providing an…...

2+ mon, 2+ week ago   (219+ words) Wilmington, NC, June 25, 2026 -- KyneRx has officially launched its nationwide telehealth platform, expanding access to personalized hormone optimization services for adults seeking convenient, physician-guided care from the comfort of home. The platform offers virtual consultations, individualized treatment plans, and ongoing clinical…...

2+ mon, 3+ week ago   (150+ words) -- First clinical authorization for an in vivo Prime Editing therapy from Prime Medicine -- -- PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing allele in North America and Europe -- -- Initiation of Phase 1/2 clinical trial expected in second half of 2026; initial…...

3+ mon, 1+ week ago   (384+ words) Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1) - Registrational expansion cohort enrolled 71 participants; topline data planned for Q1 2027 - WALTHAM, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage…...

3+ mon, 1+ week ago   (504+ words) New Technology Expands Daxor’s Diagnostic Capabilities to Enable Continuous, Remote Tracking of Blood Volume Status Using Wearable Sensors, Enhanc... Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor New Technology Expands Daxor’s Diagnostic Capabilities to Enable Continuous, Remote…...

3+ mon, 1+ week ago   (471+ words) Fully recruited Phase 2 trial evaluates RJx-01 in older adults with COPD-induced muscle weakness and sarcopenia, an area with no approved pharmaco... Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia - Fully recruited Phase 2 trial…...

3+ mon, 1+ week ago   (224+ words) Cerene is an endometrial cryotherapy treatment that is non-hormonal, incision-free, and designed to be performed in any site of service without the need for general anesthesia. The procedure takes approximately 2.5 minutes and offers women a modern alternative to more invasive…...